Nelson W, Haffner M, Yegnasubramanian S
Am J Clin Exp Urol. 2018; 6(2):107-113.
PMID: 29666839
PMC: 5902729.
Gawecka J, Ribas-Maynou J, Benet J, Ward W
Asian J Androl. 2015; 17(4):610-5.
PMID: 25926613
PMC: 4492052.
DOI: 10.4103/1008-682X.153853.
Ribas-Maynou J, Gawecka J, Benet J, Ward W
Mol Hum Reprod. 2013; 20(4):330-40.
PMID: 24282283
PMC: 3969540.
DOI: 10.1093/molehr/gat090.
Ganapathi R, Ganapathi M
Front Pharmacol. 2013; 4:89.
PMID: 23914174
PMC: 3729981.
DOI: 10.3389/fphar.2013.00089.
Walker L, Perkins E, Kratz F, Raucher D
Int J Pharm. 2012; 436(1-2):825-32.
PMID: 22850291
PMC: 3465682.
DOI: 10.1016/j.ijpharm.2012.07.043.
Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?.
Haffner M, De Marzo A, Meeker A, Nelson W, Yegnasubramanian S
Clin Cancer Res. 2011; 17(12):3858-64.
PMID: 21385925
PMC: 3117909.
DOI: 10.1158/1078-0432.CCR-10-2044.
Regulating DNA supercoiling: sperm points the way.
Ward W
Biol Reprod. 2011; 84(5):841-3.
PMID: 21248288
PMC: 3080416.
DOI: 10.1095/biolreprod.111.090951.
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.
Haffner M, Aryee M, Toubaji A, Esopi D, Albadine R, Gurel B
Nat Genet. 2010; 42(8):668-75.
PMID: 20601956
PMC: 3157086.
DOI: 10.1038/ng.613.
Drug Stimulated DNA Cleavage Mediated by Cauliflower Topoisomerase II.
Sorensen B, Fukata H, Jensen P, Andersen A, Christiansen K, Fukasawa H
Plant Physiol. 1991; 95(2):659-62.
PMID: 16668035
PMC: 1077584.
DOI: 10.1104/pp.95.2.659.
Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis.
Agostinho M, Rino J, Braga J, Ferreira F, Steffensen S, Ferreira J
Mol Biol Cell. 2004; 15(5):2388-400.
PMID: 14978217
PMC: 404031.
DOI: 10.1091/mbc.e03-08-0558.
Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells.
Matsumoto Y, Takano H, Kunishio K, Nagao S, Fojo T
Jpn J Cancer Res. 2001; 92(7):778-84.
PMID: 11473729
PMC: 5926780.
DOI: 10.1111/j.1349-7006.2001.tb01161.x.
Oral chemotherapy in the treatment of hormone-refractory prostate cancer.
Pienta K, Kamradt J, Smith D
Drugs. 2000; 58 Suppl 3:127-31.
PMID: 10711851
DOI: 10.2165/00003495-199958003-00017.
Influence of topoisomerase II on the formation of oxygen-dependent radiation-induced DNA damage.
Zhang H, Wheeler K
Br J Cancer Suppl. 1996; 27:S196-9.
PMID: 8763879
PMC: 2150016.
Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms.
Biersack H, Jensen S, Gromova I, NIELSEN I, Westergaard O, Andersen A
Proc Natl Acad Sci U S A. 1996; 93(16):8288-93.
PMID: 8710863
PMC: 38663.
DOI: 10.1073/pnas.93.16.8288.
Analysis of functional domain organization in DNA topoisomerase II from humans and Saccharomyces cerevisiae.
Jensen S, Andersen A, Kjeldsen E, Biersack H, Olsen E, Andersen T
Mol Cell Biol. 1996; 16(7):3866-77.
PMID: 8668204
PMC: 231383.
DOI: 10.1128/MCB.16.7.3866.
Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.
Schwartz G, Teicher B, Eder Jr J, Korbut T, Holden S, Ara G
Cancer Chemother Pharmacol. 1993; 32(6):455-62.
PMID: 8258194
DOI: 10.1007/BF00685890.
Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.
Holden S, Teicher B, Robinson M, Northey D, Rosowsky A
Cancer Chemother Pharmacol. 1995; 36(2):165-71.
PMID: 7767954
DOI: 10.1007/BF00689203.
Kinetic resistance to anticancer agents.
Dimanche-Boitrel M, Garrido C, Chauffert B
Cytotechnology. 1993; 12(1-3):347-56.
PMID: 7764456
DOI: 10.1007/BF00744672.
DNA topoisomerase II alpha is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2.
Taagepera S, Rao P, Drake F, Gorbsky G
Proc Natl Acad Sci U S A. 1993; 90(18):8407-11.
PMID: 7690961
PMC: 47365.
DOI: 10.1073/pnas.90.18.8407.
Three-dimensional organization of Drosophila melanogaster interphase nuclei. II. Chromosome spatial organization and gene regulation.
Hochstrasser M, Sedat J
J Cell Biol. 1987; 104(6):1471-83.
PMID: 3108265
PMC: 2114521.
DOI: 10.1083/jcb.104.6.1471.